TAF9 Antikörper (AA 1-172)

Produktnummer ABIN1682962

Produktdetails anti-TAF9 Antikörper

Target: TAF9 (RNA Polymerase II TBP-Associated Factor Subunit G (TAF9))

Bindungsspezifität: AA 1-172

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TAF9 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Sequenz: MLLPNILLTG TPGVGKTTLG KELASKSGLK YINVGDLARE EQLYDGYDEE YDCPILDEDR VVDELDNQMR EGGVIVDYHG CDFFPERWFH IVFVLRTDTN VLYERLETRG YNEKKLTDNI QCEIFQVLYE EATASYKEEI VHQLPSNKPE ELENNVDQIL KWIEQWIKDH NS

Kreuzreaktivität: Human, Ratte

Produktmerkmale: Polyclonal Antibodies

Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 1-172 of human TAF9 (NP_057367.1).

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB,1:500 - 1:2000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Avoid freeze / thaw cycles.

Details zu TAF9

Target: TAF9 (RNA Polymerase II TBP-Associated Factor Subunit G (TAF9))

Andere Bezeichnung: TAF9 (TAF9 Produkte)

Synonyme: AK6 antikoerper, CGI-137 antikoerper, CINAP antikoerper, CIP antikoerper, MGC:1603 antikoerper, MGC:3647 antikoerper, MGC:5067 antikoerper, TAF2G antikoerper, TAFII31 antikoerper, TAFII32 antikoerper, TAFIID32 antikoerper, hCINAP antikoerper, 2310012M09Rik antikoerper, 2810046E22Rik antikoerper, 4921516M08Rik antikoerper, AA673500 antikoerper, AU045423 antikoerper, Ak6 antikoerper, Taf2g antikoerper, im:7089279 antikoerper, wu:fb16h03 antikoerper, zgc:153410 antikoerper, TATA-box binding protein associated factor 9 antikoerper, adenylate kinase 6 L homeolog antikoerper, adenylate kinase isoenzyme 6-like antikoerper, SAGA complex/ transcription initiation factor Taf9 antikoerper, TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor antikoerper, TAF9 antikoerper, Taf9 antikoerper, ak6.L antikoerper, LOC100355082 antikoerper, taf9 antikoerper

Hintergrund: Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes one of the smaller subunits of TFIID that binds to the basal transcription factor GTF2B as well as to several transcriptional activators such as p53 and VP16. In human, TAF9 and AK6 (GeneID: 102157402) are two distinct genes that share 5' exons. A similar but distinct gene (TAF9L) has been found on the X chromosome and a pseudogene has been identified on chromosome 19. Alternative splicing results in multiple transcript variants.,TAF9,MGC:5067,STAF31/32,TAF2G,TAFII-31,TAFII-32,TAFII31,TAFII32,TAFIID32,Epigenetics & Nuclear Signaling,TAF9

Molekulargewicht: 28 kDa

Gen-ID: 6880

UniProt: Q16594

Pathways: Negative Regulation of intrinsic apoptotic Signaling